Rabeprazole vs esomeprazole in non-erosive gastro-esophageal reflux disease: A randomized, double-blind study in urban Asia

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 20

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

454

HTML

3248

Figures (1-3)

145

Tables (1-2)

129

Sum=3976

May 28, 2005 (publication date) through Apr 23, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. May 28, 2005; 11(20): 3091-3098
Published online May 28, 2005. doi: 10.3748/wjg.v11.i20.3091

Table 1 Demographic and baseline characteristics of patients enrolled.

Number of subjects enrolled	Total 127	Rabeprazole 63	Esomeprazole 64	P
Gender (%)
Female	62 (48.8)	25 (39.7)	37 (57.8)	P = 0.051¹
Male	65 (51.2)	38 (60.3)	27 (42.2)
Race (%)
Chinese	101 (79.5)	52 (82.5)	49 (76.6)	P = 0.872¹
Malay	9 (7.1)	4 (6.3)	5 (7.8)
Indian	15 (11.8)	6 (9.5)	9 (14.1)
Other	2 (1.6)	1 (1.6)	1 (1.6)
Age (yr)
Mean (SD)	38.9 (10.6)	39.3 (11.2)	38.4 (10.0)	P = 0.629²
History of GERD symptoms (yr)
Mean (SD)	3.6 (4.5)	3.2 (4.2)	3.9 (4.7)	P = 0.373²
Tobacco use, N (%)
Yes	11 (8.7)	4 (6.3)	7 (10.9)	P = 0.243¹
No	116 (91.3)	59 (93.7)	57 (89.1)
Alcohol use, N (%)
Yes	20 (15.7)	9 (14.3)	11 (17.2)	P = 0.486¹
No	107 (84.3)	54 (85.7)	53 (82.8)
Previous medication for reflux disease
Yes	77 (60.6)	35 (55.6)	42 (65.6)	P = 0.279¹
No	50 (39.4)	28 (44.4)	22 (34.4)
H pylori status
Positive	50	24 (45.3)	26 (44.0)
Negative	62	29 (54.7)	33 (56.0)	P = 0.95³
(Not available	15	10	5

Test¹ Fisher’s exact test; Test²t-test; Test³χ² test

Citation: Fock K, Teo E, Ang T, Chua T, Ng T, Tan Y. Rabeprazole vs esomeprazole in non-erosive gastro-esophageal reflux disease: A randomized, double-blind study in urban Asia. World J Gastroenterol 2005; 11(20): 3091-3098
URL: https://www.wjgnet.com/1007-9327/full/v11/i20/3091.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i20.3091